MicroRNA-155 regulates alpha-synuclein-induced inflammatory responses in models of Parkinson disease

Journal of Neuroscience

Volumn 36, Issue 8, 2016, Pages 2383-2390

  Thome, Aaron D ^a   Harms, Ashley S ^a   Volpicelli Daley, Laura A ^a   Standaert, David G ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Microglia; MicroRNA 155; Neurodegeneration; Neuroinflammation; Parkinson disease; synuclein

Indexed keywords

ALPHA SYNUCLEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MICRORNA 155; AUTACOID; MICRORNA; MIRN155 MICRORNA, MOUSE;

ADENO ASSOCIATED VIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONFOCAL LASER MICROSCOPY; GENE DELETION; GENE OVEREXPRESSION; GLIOSIS; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MICROGLIA; MOUSE; NERVE DEGENERATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; DISEASE MODEL; KNOCKOUT MOUSE; METABOLISM; NEWBORN; PATHOLOGY; PHYSIOLOGY;

ALPHA-SYNUCLEIN; ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; DISEASE MODELS, ANIMAL; INFLAMMATION MEDIATORS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROGLIA; MICRORNAS; PARKINSON DISEASE;

EID: 84959440118     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.3900-15.2016     Document Type: Article

References (49)

1. Alexandrov PN, Dua P, Hill JM, Bhattacharjee S, Zhao Y, Lukiw WJ (2012) microRNA (miRNA) speciation in Alzheimer's disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF). Int J Biochem Mol Biol 3:365-373. Medline
2. Allen Reish HE, Standaert DG (2015) Role of alpha-synuclein in inducing innate and adaptive immunity in Parkinson disease. J Parkinsons Dis 5:1-19. Medline
3. Appel SH (2012) Inflammation in Parkinson's disease: cause or consequence? Mov Disord 27:1075-1077. CrossRef Medline
4. Brochard V, Combadière B, Prigent A, Laouar Y, Perrin A, Beray-Berthat V, Bonduelle O, Alvarez-Fischer D, Callebert J, Launay JM, Duyckaerts C, Flavell RA, Hirsch EC, Hunot S (2009) Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J Clin Invest 119:182-192. Medline
5. Butovsky O, Siddiqui S, Gabriely G, Lanser AJ, Dake B, Murugaiyan G, Doykan CE, Wu PM, Gali RR, Iyer LK, Lawson R, Berry J, Krichevsky AM, Cudkowicz ME, Weiner HL (2012) Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. J Clin Invest 122:3063-3087. CrossRef Medline
6. Butovsky O, Jedrychowski MP, Cialic R, Krasemann S, Murugaiyan G, Fanek Z, Greco DJ, Wu PM, Doykan CE, Kiner O, Lawson RJ, Frosch MP, Pochet N, Fatimy RE, Krichevsky AM, Gygi SP, Lassmann H, Berry J, Cudkowicz ME, Weiner HL (2015) Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice. Ann Neurol 77: 75-99. CrossRef Medline
7. Cao S, Theodore S, Standaert DG (2010) Fcgamma receptors are required for NF-kappaB signaling, microglial activation and dopaminergic neurodegeneration in an AAV-synuclein mouse model of Parkinson's disease. Mol Neurodegener 5:42. CrossRef Medline
8. Cao S, Standaert DG, Harms AS (2012) The gamma chain subunit of Fc receptors is required for alpha-synuclein-induced pro-inflammatory signaling in microglia. J Neuroinflammation 9:259. CrossRef Medline
9. Codolo G, Plotegher N, Pozzobon T, Brucale M, Tessari I, Bubacco L, de Bernard M (2013) Triggering of inflammasome by aggregated alphasynuclein, an inflammatory response in synucleinopathies. PLoS One 8:e55375. CrossRef Medline
10. Devier DJ, Lovera JF, Lukiw WJ (2015) Increase in NF-kappaB-sensitive miRNA-146a and miRNA-155 in multiple sclerosis (MS) and proinflammatory neurodegeneration. Front Mol Neurosci 8:5. Medline
11. Divekar AA, Dubey S, Gangalum PR, Singh RR (2011) Dicer insufficiency and microRNA-155 overexpression in lupus regulatory T cells: an apparent paradox in the setting of an inflammatory milieu. J Immunol 186: 924-930. CrossRef Medline
12. Femminella GD, Ferrara N, Rengo G (2015) The emerging role of microRNAs in Alzheimer's disease. Front Physiol 6:40. Medline
13. Gerhard A, Pavese N, Hotton G, Turkheimer F, Es M, Hammers A, Eggert K, Oertel W, Banati RB, Brooks DJ (2006) In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease. Neurobiol Dis 21:404-412. CrossRef Medline
14. Hamza TH, Zabetian CP, Tenesa A, Laederach A, Montimurro J, Yearout D, Kay DM, Doheny KF, Paschall J, Pugh E, Kusel VI, Collura R, Roberts J, Griffith A, Samii A, Scott WK, Nutt J, Factor SA, PayamiH (2010) Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nat Genet 42:781-785. CrossRef Medline
15. Harms AS, TanseyMG (2013) Isolation of murine postnatal brain microglia for phenotypic characterization using magnetic cell separation technology. Methods Mol Biol 1041:33-39. CrossRef Medline
16. Harms AS, Lee JK, Nguyen TA, Chang J, Ruhn KM, Treviño I, Tansey MG (2012) Regulation of microglia effector functions by tumor necrosis factor signaling. Glia 60:189 -202. CrossRef Medline
17. Harms AS, Cao S, Rowse AL, Thome AD, Li X, Mangieri LR, Cron RQ, Shacka JJ, Raman C, Standaert DG (2013) MHCII is required for alphasynuclein- induced activation of microglia, CD4 T cell proliferation, and dopaminergic neurodegeneration. J Neurosci 33:9592-9600. CrossRef Medline
18. Hirsch EC, Hunot S (2009) Neuroinflammation in Parkinson's disease: a target for neuroprotection? Lancet Neurol 8:382-397. CrossRef Medline
19. Junker A, Krumbholz M, Eisele S, Mohan H, Augstein F, Bittner R, Lassmann H, Wekerle H, Hohlfeld R, Meinl E (2009) microRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. Brain 132:3342-3352. CrossRef Medline
20. Klegeris A, Pelech S, Giasson BI, Maguire J, Zhang H, McGeer EG, McGeer PL (2008) Alpha-synuclein activates stress signaling protein kinases in THP-1 cells and microglia. Neurobiol Aging 29:739 -752. CrossRef Medline
21. Koval ED, Shaner C, Zhang P, du Maine X, Fischer K, Tay J, Chau BN, WuGF, Miller TM (2013) Method for widespread microRNA-155 inhibition prolongs survival in ALS-model mice. Hum Mol Genet 22:4127- 4135. CrossRef Medline
22. Lee EJ, Woo MS, Moon PG, Baek MC, Choi IY, Kim WK, Junn E, Kim HS (2010) Alpha-synuclein activates microglia by inducing the expressions of matrix metalloproteinases and the subsequent activation of proteaseactivated receptor-1. J Immunol 185:615- 623. CrossRef Medline
23. Liu G, Abraham E (2013) microRNAs in immune response and macrophage polarization. Arterioscler Thromb Vasc Biol 33:170 -177. CrossRef Medline
24. Long L, Yu P, Liu Y, Wang S, Li R, Shi J, Zhang X, Li Y, Sun X, Zhou B, Cui L, Li Z (2013) Upregulated microRNA-155 expression in peripheral blood mononuclear cells and fibroblast-like synoviocytes in rheumatoid arthritis. Clin Dev Immunol 2013:296139. Medline
25. Lopez-Ramirez MA, Wu D, Pryce G, Simpson JE, Reijerkerk A, King-Robson J, Kay O, de Vries HE, Hirst MC, Sharrack B, Baker D, Male DK, Michael GJ, Romero IA (2014) microRNA-155 negatively affects blood-brain barrier function during neuroinflammation. FASEB J 28:2551-2565. CrossRef Medline
26. Louafi F, Martinez-Nunez RT, Sanchez-Elsner T (2010) microRNA-155 targets SMAD2 and modulates the response of macrophages to transforming growth factor-{beta}. J Biol Chem 285:41328-41336. CrossRef Medline
27. Luk KC, Song C, O'Brien P, Stieber A, Branch JR, Brunden KR, Trojanowski JQ, Lee VM (2009) Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Proc Natl Acad Sci U S A 106:20051-20056. CrossRef Medline
28. Luk KC, Kehm VM, Zhang B, O'Brien P, Trojanowski JQ, Lee VM (2012a) Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice. J Exp Med 209:975-986. CrossRef Medline
29. Luk KC, Kehm V, Carroll J, Zhang B, O'Brien P, Trojanowski JQ, Lee VM (2012b) Pathological alpha-synuclein transmission initiates Parkinsonlike neurodegeneration in nontransgenic mice. Science 338:949 -953. CrossRef Medline
30. McGeer PL, Itagaki S, Boyes BE, McGeer EG (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38:1285-1291. CrossRef Medline
31. Mogi M, Harada M, Riederer P, Narabayashi H, Fujita K, Nagatsu T (1994a) Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. Neurosci Lett 165: 208-210. CrossRef Medline
32. Mogi M, Harada M, Kondo T, Riederer P, Inagaki H, Minami M, Nagatsu T (1994b) Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients. Neurosci Lett 180:147-150. CrossRef Medline
33. Moore CS, Rao VT, Durafourt BA, Bedell BJ, Ludwin SK, Bar-Or A, Antel JP (2013) miR-155 as a multiple sclerosis-relevant regulator of myeloid cell polarization. Ann Neurol 74:709 -720. CrossRef Medline
34. O'Connell RM, Chaudhuri AA, Rao DS, Baltimore D (2009) Inositol phosphatase SHIP1 is a primary target of miR-155. Proc Natl Acad Sci U S A 106:7113-7118. CrossRef Medline
35. Ponomarev ED, Veremeyko T, Weiner HL (2013) microRNAs are universal regulators of differentiation, activation, and polarization of microglia and macrophages in normal and diseased CNS. Glia 61:91-103. CrossRef Medline
36. Ramsey CP, Tansey MG (2014) A survey from 2012 of evidence for the role of neuroinflammation in neurotoxin animal models of Parkinson's disease and potential molecular targets. Exp Neurol 256:126 -132. CrossRef Medline
37. Reynolds AD, Kadiu I, Garg SK, Glanzer JG, Nordgren T, Ciborowski P, Banerjee R, Gendelman HE (2008a) Nitrated alpha-synuclein and microglial neuroregulatory activities. J Neuroimmune Pharmacol 3:59 -74. CrossRef Medline
38. Reynolds AD, Glanzer JG, Kadiu I, Ricardo-Dukelow M, Chaudhuri A, Ciborowski P, Cerny R, Gelman B, Thomas MP, Mosley RL, Gendelman HE (2008b) Nitrated alpha-synuclein-activated microglial profiling for Parkinson's disease. J Neurochem 104:1504 -1525. CrossRef Medline
39. Roodveldt C, Labrador-Garrido A, Gonzalez-Rey E, Lachaud CC, Guilliams T, Fernandez-Montesinos R, Benitez-Rondan A, Robledo G, Hmadcha A, Delgado M, Dobson CM, Pozo D (2013) Preconditioning of microglia by alpha-synuclein strongly affects the response induced by toll-like receptor (TLR) stimulation. PLoS One 8:e79160. CrossRef Medline
40. St Martin JL, Klucken J, Outeiro TF, Nguyen P, Keller-McGandy C, Cantuti- Castelvetri I, Grammatopoulos TN, Standaert DG, Hyman BT, McLean PJ (2007) Dopaminergic neuron loss and up-regulation of chaperone proteinmRNAinduced by targeted over-expression of alpha-synuclein in mouse substantia nigra. J Neurochem 100:1449 -1457. Medline
41. Thai TH, Calado DP, Casola S, Ansel KM, Xiao C, Xue Y, Murphy A, Frendewey D, Valenzuela D, Kutok JL, Schmidt-Supprian M, Rajewsky N, Yancopoulos G, Rao A, Rajewsky K (2007) Regulation of the germinal center response by microRNA-155. Science 316:604-608. CrossRef Medline
42. Theodore S, Cao S, McLean PJ, Standaert DG (2008) Targeted overexpression of human alpha-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease. J Neuropathol Exp Neurol 67:1149 -1158. CrossRef Medline
43. Thome AD, Standaert DG, Harms AS (2015) Fractalkine signaling regulates the inflammatory response in an alpha-synuclein model of Parkinson disease. PLoS One 10:e0140566. CrossRef Medline
44. Volpicelli-Daley LA, Luk KC, Patel TP, Tanik SA, Riddle DM, Stieber A, Meaney DF, Trojanowski JQ, Lee VM (2011) Exogenous alphasynuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 72:57-71. CrossRef Medline
45. Volpicelli-Daley LA, Luk KC, Lee VM (2014) Addition of exogenous alphasynuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous alpha-synuclein to Lewy body and Lewy neurite-like aggregates. Nat Protoc 9:2135-2146. CrossRef Medline
46. Woodbury ME, Freilich RW, Cheng CJ, Asai H, Ikezu S, Boucher JD, Slack F, Ikezu T (2015) miR-155 is essential for inflammation-induced hippocampal neurogenic dysfunction. J Neurosci 35:9764 -9781. CrossRef Medline
47. Yang Y, Yang L, Liang X, Zhu G (2015) microRNA-155 promotes atherosclerosis inflammation via targeting SOCS1. Cell Physiol Biochem 36: 1371-1381. CrossRef Medline
48. Zhang J, Cheng Y, Cui W, Li M, Li B, Guo L (2014) microRNA-155 modulates Th1 and Th17 cell differentiation and is associated with multiple sclerosis and experimental autoimmune encephalomyelitis. J Neuroimmunol 266:56-63. CrossRef Medline
49. Zhang W, Wang T, Pei Z, Miller DS, Wu X, Block ML, Wilson B, Zhang W, Zhou Y, Hong JS, Zhang J (2005) Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease. FASEB J 19:533-542. CrossRef Medline